ACAD - ACADIA Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 53.05B
Enterprise Value 32.87B
Trailing P/E N/A
Forward P/E 1-40.12
PEG Ratio (5 yr expected) 1-0.36
Price/Sales (ttm)24.43
Price/Book (mrq)9.08
Enterprise Value/Revenue 322.98
Enterprise Value/EBITDA 6-9.91

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017


Profit Margin -231.71%
Operating Margin (ttm)-234.11%

Management Effectiveness

Return on Assets (ttm)-38.65%
Return on Equity (ttm)-67.80%

Income Statement

Revenue (ttm)124.9M
Revenue Per Share (ttm)1.02
Quarterly Revenue Growth (yoy)264.20%
Gross Profit (ttm)111.84M
EBITDA -289.7M
Net Income Avi to Common (ttm)-289.4M
Diluted EPS (ttm)-2.3610
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)341.34M
Total Cash Per Share (mrq)2.74
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)7.62
Book Value Per Share (mrq)2.69

Cash Flow Statement

Operating Cash Flow (ttm)-217.86M
Levered Free Cash Flow (ttm)-112.15M

Trading Information

Stock Price History

Beta 3.99
52-Week Change 3-30.76%
S&P500 52-Week Change 315.95%
52 Week High 341.2000
52 Week Low 322.3500
50-Day Moving Average 328.0953
200-Day Moving Average 331.3635

Share Statistics

Avg Vol (3 month) 32.04M
Avg Vol (10 day) 31.65M
Shares Outstanding 5124.7M
Float 97.38M
% Held by Insiders 10.41%
% Held by Institutions 1100.14%
Shares Short 38.7M
Short Ratio 34.98
Short % of Float 311.20%
Shares Short (prior month) 36.59M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A